A G Protein-coupled Receptor Responsive to Bile Acids
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
So far some nuclear receptors for bile acids have been identified. However, no cell surface receptor for bile acids has yet been reported. We found that a novel G protein-coupled receptor, TGR5, is responsive to bile acids as a cell-surface receptor. Bile acids specifically induced receptor internalization, the activation of extracellular signal-regulated kinase mitogen-activated protein kinase, the increase of guanosine 5'-O-3-thio-triphosphate binding in membrane fractions, and intracellular cAMP production in Chinese hamster ovary cells expressing TGR5. Our quantitative analyses for TGR5 mRNA showed that it was abundantly expressed in monocytes/macrophages in human and rabbit. Treatment with bile acids was found to suppress the functions of rabbit alveolar macrophages including phagocytosis and lipopolysaccharide-stimulated cytokine productions. We prepared a monocytic cell line expressing TGR5 by transfecting a TGR5 cDNA into THP-1 cells that did not express TGR5 originally. Treatment with bile acids suppressed the cytokine productions in the THP-1 cells expressing TGR5, whereas it did not influence those in the original THP-1 cells, suggesting that TGR5 is implicated in the suppression of macrophage functions by bile acids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, KO of the BA receptors FXR (Nr1h4), TGR5 (Gpbar1), and VDR (Vdr) (36-38) did not rescue T cell function in LCA-fed mice (fig. S10, F and G).”
From Bile acid synthesis impedes tumor-specific T cell responses during liver cancer (2025) · cites this paper as [36]
In the citing paper
“activation of GPBAR1 on macrophages and Kupffer cells by synthetic agonists inhibits the expression of LPS-induced pro-inflammatory cytokines by interfering with NF-κB-dependent transcription.”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Kawamata et al., 2003
In the citing paper
“Both receptors can be activated by primary and secondary bile acids alike (Kawamata et al., 2003; Makishima et al., 1999; Maruyama et al., 2002; Parks et al., 1999; H. Wang et al., 1999).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Kawamata et al., 2003
In the citing paper
“GPBAR1, as the name suggests, is a Gs-protein-coupled receptor. Binding by bile acids triggers an increase in intracellular cAMP levels and the activation of ERK (Kawamata et al., 2003; Maruyama et al., 2002).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Kawamata et al., 2003
In the citing paper
“This has been linked to direct inhibition of NF-κB activation, but is also consistent with a model of transcriptional competition between NF-κB and the cAMP-activated transcription factor cAMP response element binding protein (CREB) (C. Guo et al., 2015; Kawamata et al., 2003; Keitel et al., 2008; Pols et al., 2011; Y.-D. Wang et al., 2011; Wen et al., 2010).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Kawamata et al., 2003
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1
Xu, Y., Zhu, K., Hong, G., Wu, W., Baudhuin, L. M., Xiao, Y.-J., & Damron, D. S. (2000) · Nature Cell Biology · doi:10.1038/35010529 · Cited by 289
RetractedCD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,987
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
SOSUI: classification and secondary structure prediction system for membrane proteins.
Hirokawa, T., Boon-Chieng, S., & Mitaku, S. (1998) · Bioinformatics · doi:10.1093/bioinformatics/14.4.378 · Cited by 1,936
An oxysterol signalling pathway mediated by the nuclear receptor LXRα
Janowski, B. A., Willy, P. J., Devi, T. R., Falck, J. R., & Mangelsdorf, D. J. (1996) · Nature · doi:10.1038/383728a0 · Cited by 1,591
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
Staudinger, J. L., Goodwin, B., Jones, S. A., Hawkins-Brown, D., MacKenzie, K. I., LaTour, A., Liu, Y., Klaassen, C. D., Brown, K. K., Reinhard, J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051551698 · Cited by 1,379
A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis
Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y., & Shimizu, T. (1997) · Nature · doi:10.1038/42506 · Cited by 971
Russell, D. W., & Setchell, K. D. R. (1992) · Biochemistry · doi:10.1021/bi00135a001 · Cited by 819
The Pregnane X Receptor: A Promiscuous Xenobiotic Receptor That Has Diverged during Evolution
Jones, S. A., Moore, L. B., Shenk, J. L., Wisely, G. B., Hamilton, G. A., McKee, D. D., Tomkinson, N. C. O., LeCluyse, E. L., Lambert, M. H., Willson, T. M., et al. (2000) · Molecular Endocrinology · doi:10.1210/me.14.1.27 · Cited by 672
Research works printed but not linked: 3
- Jones, 2000, Mol. Endocrinol., 14, 27, 10.1210/mend.14.1.0409 · doi:10.1210/mend.14.1.0409 · Paper page
- Keane, 1984, Surgery, 95, 439
- Kimmings, 1995, J. Am. Coll. Surg., 181, 567
Cited by
Items 801–900 of 1,002
Ipharraguerre, I. R., Tedó, G., Menoyo, D., Nuria, D. D. C., Holst, J. J., Nofrarías, M., Mereu, A., & Burrin, D. G. (2013) · Journal of Nutrition · doi:10.3945/jn.113.177865 · Cited by 28
Festa, C., Marino, S. D., Carino, A., Sepe, V., Marchianò, S., Cipriani, S., Leva, F. S. D., Limongelli, V., Monti, M. C., Capolupo, A., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00162 · Cited by 28
“…the interaction with several nuclear receptors (NRs) and cell surface G-protein-coupled receptors (G-PCRs), including the G proteincoupled bile acid receptor GPBAR1 (also known as TGR5 or M-BAR) (Maruyama et al., 2002; Kawamata et al., 2003; Fiorucci and Distrutti, 2015; Copple and Li, 2016).”
BackgroundNakhi, A., McDermott, C. M., Stoltz, K. L., John, K., Hawkinson, J. E., Ambrose, E. A., Khoruts, A., Sadowsky, M. J., & Dosa, P. I. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00770 · Cited by 28
Chen, P., Deng, D., Wei, T., Wu, Z., Zhang, B., Yuan, Q., Liang, G., Liu, Y., & Yin, P. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1039786 · Cited by 36
“TLCA was the strongest activator of TGR5 Frontiers in Endocrinology 11 among all the BAs and promoted the occurrence of liver cancer by activating the TGR5 (45).”
BackgroundYao, Q., Chen, W., Yu, Y., Gao, F., Zhou, J., Wu, J., Pan, Q., Yang, J., Zhou, L., Yu, J., et al. (2023) · Research · doi:10.34133/research.0207 · Cited by 42
Jing, J., Guo, J., Dai, R., Zhu, C., & Zhang, Z. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1252907 · Cited by 28
“Bile acids reduce the transcriptional activity of NF-κB by activating the cell surface membrane receptor TGR5 to downregulate the levels of proinflammatory cytokines, which in turn inhibits inflammation in AS plaques of Ldlr−/− mice and reduces the content of macrophages and lipid load in the plaques (Pols et al., 201…”
BackgroundInfluentialLeonhardt, J., Dorresteijn, M. J., Neugebauer, S., Mihaylov, D., Kunze, J., Rubio, I., Hohberger, F.-S., Leonhardt, S., Kiehntopf, M., Stahl, K., et al. (2023) · Critical Care · doi:10.1186/s13054-023-04620-5 · Cited by 30
“TGR5 activation has been reported to induce monocyte dysfunction, as characterized by a decrease in the release of tumor necrosis factor α (TNFα), IL-1β and IL-6 upon LPS stimulation and an unaltered release of anti-inflammatory IL-10 [1, 7].”
BackgroundInfluentialCutting Edge Issues in Primary Sclerosing Cholangitis
Bowlus, C. L. (2010) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-010-8221-3 · Cited by 29
“At chromosome 2q35, the bile acid receptor TGR5 gene is one of the most plausible disease genes as it is strongly expressed in monocytes and macrophages, and inhibits the release of inflammatory cytokines from activated macrophages, including Kupffer cells [38, 39].”
BackgroundMacchiarulo, A., Gioiello, A., Thomas, C., Massarotti, A., Nuti, R., Rosatelli, E., Sabbatini, P., Schoonjans, K., Auwerx, J., & Pellicciari, R. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci800196h · Cited by 26
Redefining the TGR5 Triterpenoid Binding Pocket at the C‐3 Position
Genet, C., Schmidt, C., Strehle, A., Schoonjans, K., Auwerx, J. H., Saladin, R., & Wagner, A. (2010) · ChemMedChem · doi:10.1002/cmdc.201000329 · Cited by 28
Duboc, H., Aelion, H., Rainteau, D. P., Rajca, S., Sokol, H., Humbert, L., Farabos, D., Coffin, B., Weber, S., Porcher, R., et al. (2012) · Hepatology · doi:10.1002/hep.25839 · Cited by 28
“Although the populations were small, we believe this observation connecting LCA and coronary atheroma is a field worth investigating further, as LCA is the most powerful activator of TGR5.(3) A study targeting the proinflammatory mechanism acting in atheroma plaque evidenced that the activation of the TGR5 receptor si…”
BackgroundInfluentialMorimoto, K., 渡辺, 光., Sugizaki, T., Irie, J., & Itoh, H. (2016) · Endocrinology · doi:10.1210/en.2015-1551 · Cited by 32
“CRE is a probable target of TGR5mediated signaling pathway because TGR5 stimulation increases intracellular cAMP levels (1, 2, 9).”
BackgroundResultRole of gut microbial metabolites in nonalcoholic fatty liver disease
Zhao, Z. H., Lai, J. K., Qiao, L., & Fan, J. (2019) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12709 · Cited by 30
“TGR5, also known as membrane-type bile acid receptor, was the first GPCR reported to be activated by bile acids.(54) Compared with FXR, which is highly expressed in the liver and the ileum, TGR5 is widely expressed in various human tissues, such as the liver and the spleen.”
BackgroundYang, Z., Li, J., Xiong, F., Huang, J., Chen, C., Liu, P., & Huang, H. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.06.005 · Cited by 30
“In the human body, TGR5 is highly expressed in the spleen and placenta, followed by the kidney, lung, liver, stomach, small intestine, adipose tissue, and bone marrow [7].”
BackgroundWang, Y., Yu, J., Chen, B., Jin, W., Wang, M., Chen, X., Jian, M., Sun, L., & Piao, C. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1481270 · Cited by 33
“Studies have shown that secondary BAs exhibit markedly higher af fi nity for TGR5 than primary BAs, with LCA emerging as the most potent natural agonist for TGR5 (159, 161).”
Zhang, Z., Guo, X., Liu, J., Gu, Y.-J., Ji, X.-W., Zhu, S., Xie, J., & Guo, F. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05922-0 · Cited by 30
Misawa, N., Higurashi, T., Takatsu, T., Iwaki, M., Kobayashi, T., Yoshihara, T., Ashikari, K., Kessoku, T., Fuyuki, A., Matsuura, T., et al. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15950 · Cited by 29
Salomatina, O. V., Popadyuk, I. I., Zakharenko, A. L., Zakharova, O. D., Chepanova, A. A., Dyrkheeva, N. S., Комарова, Н. И., Reynisson, J., Anarbaev, R. O., Salakhutdinov, N. F., et al. (2020) · Steroids · doi:10.1016/j.steroids.2020.108771 · Cited by 27
Mechanistic insights into the pathophysiology of cirrhotic cardiomyopathy
Desai, M. S. (2021) · Analytical Biochemistry · doi:10.1016/j.ab.2021.114388 · Cited by 31
Irradiation-Induced Intestinal Injury is Associated With Disorders of Bile Acids Metabolism
Guo, L. Q., Da, F., Gao, Q., Miao, X., Guo, J., Zhang, W., Li, J., Wang, J., & Liu, J. (2022) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2022.08.007 · Cited by 30
Zhang, M., Xiao, B., Chen, X., Ou, B., & Wang, S. (2023) · Acta Physiologica · doi:10.1111/apha.14065 · Cited by 31
“149 150–154 Macrophages can be divided into proinflammatory macrophage phenotype M1 and anti-inflammatory macrophage phenotype M2.”
BackgroundZi, Z., & Rao, Y. (2024) · Science Advances · doi:10.1126/sciadv.adj0146 · Cited by 31
“GPBAR1 (also known as TGR5 or M-BAR) is the most studied membrane receptor for BAs, which is reported to be G α s - coupled ( 24 , 25 ).”
BackgroundNomilin as an Anti-Obesity and Anti-Hyperglycemic Agent
Sato, R. (2013) · Vitamins and hormones · doi:10.1016/b978-0-12-407766-9.00018-3 · Cited by 28
Cai, K., & Sewer, M. B. (2013) · Biochemical Journal · doi:10.1042/bj20130609 · Cited by 29
Inoue, T., Wang, J.-H., Higashiyama, M., Rudenkyy, S., Higuchi, K., Guth, P. H., Engel, E., Kaunitz, J. D., & Akiba, Y. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00195.2012 · Cited by 29
Bile acid receptor TGR5 is critically involved in preference for dietary lipids and obesity
Bensalem, A., Murtaza, B., Hichami, A., Khan, A. S., Oulamara, H., Merlen, G., Berrichi, M., Agli, A.-N., Tordjmann, T., & Khan, N. A. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.108298 · Cited by 28
Zhang, L., Fu, X., Gui, T., Wang, T., Wang, Z., Kullak-Ublick, G. A., & Gai, Z. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246280 · Cited by 27
“The renal tubular cells, and immune cells including monocytes and macrophages [21,22].”
BackgroundRecent advances in regulating cholesterol and bile acid metabolism
Sato, R. (2020) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2020.1793658 · Cited by 29
Kida, T., Omori, K., Hori, M., Ozaki, H., & Murata, T. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.209288 · Cited by 28
“1A, treatment with a bile acid that has the highest affinity to GPBAR, TLCA (3 mM) (Maruyama et al., 2002; Kawamata et al., 2003), rapidly increased the TER of BAECs.”
BackgroundInfluentialUrbani, G., Rondini, E., Distrutti, E., Marchianò, S., Biagioli, M., & Fiorucci, S. (2025) · Cells · doi:10.3390/cells14080595 · Cited by 28
“GP-BAR1 is expressed by monocytes, macrophages, DCs and natural killer T (NKT) cells [267].”
Mechanisms for the metabolic success of bariatric surgery
Sandoval, D. A. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12708 · Cited by 27
Metabokines in the regulation of systemic energy metabolism
MacCannell, A. D. V., & Roberts, L. D. (2022) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2022.102286 · Cited by 26
Henin, G., Lanthier, N., & Dahlqvist, G. (2022) · Acta gastro-enterologica Belgica · doi:10.51821/85.4.10899 · Cited by 25
Gut Microbiota and Adipose Tissue Microenvironment Interactions in Obesity
Wang, C., Yi, Z., Ye, J., Shen, Z., Yang, F., & Zhu, S. (2023) · Metabolites · doi:10.3390/metabo13070821 · Cited by 26
“, Takeda G protein-coupled receptor 5 [39]).”
Sirtuins: Promising Therapeutic Targets to Treat Ischemic Stroke
Liu, Y., Wang, L., Yang, G., Chi, X., Liang, X., & Zhang, Y. (2023) · Biomolecules · doi:10.3390/biom13081210 · Cited by 27
Gao, Y., Lin, J., Ye, C., Guo, S., & Jiang, C. (2023) · Liver Research · doi:10.1016/j.livres.2023.09.002 · Cited by 36
“64,65 Recently, the structure of the TGR5-G a complex was revealed by cryo-electron microscopy, and a clear view of the mechanism that underlies TGR5 activation in response to BAs was shown.”
Collaborative Metabolism: Gut Microbes Play a Key Role in Canine and Feline Bile Acid Metabolism
Rowe, J. C., & Winston, J. A. (2024) · Veterinary Sciences · doi:10.3390/vetsci11020094 · Cited by 30
“The best characterized of these is TGR5 [95–99].”
BackgroundMuñoz, R., Carmody, J. S., Stylopoulos, N., Davis, P. J., & Kaplan, L. M. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00262.2012 · Cited by 26
Liu, L., Panzitt, K., Racedo, S., Wagner, M., Platzer, W., Zaufel, A., Theiler‐Schwetz, V., Obermayer-Pietsch, B. M., Müller, H., Höfler, G., et al. (2019) · Liver International · doi:10.1111/liv.14052 · Cited by 28
Kaneko, Y., Sano, M., Seno, K., Oogaki, Y., Takahashi, H., Ohkuchi, A., Yokozawa, M., Yamauchi, K., Iwata, H., Kuwayama, T., et al. (2019) · Nutrients · doi:10.3390/nu11050970 · Cited by 29
“It has been reported that overexpression of TGR5 in THP-1 cells (a human monocyte cell line) decreases the production of LPS-stimulated cytokine [29].”
BackgroundDeng, L., Chen, X., Zhong, Y., Wen, X., Cai, Y., Li, J., Fan, Z., & Feng, J. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6372786 · Cited by 30
“TGR5 is activated by bile acids and mediates the endocrine effects of bile acids on energy balance, inflammation, digestion, and sensation [13].”
BackgroundInfluentialThe bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagy
Carino, A., Marchianò, S., Biagioli, M., Scarpelli, P., Bordoni, M., Giorgio, C. D., Roselli, R., Fiorucci, C., Monti, M. C., Distrutti, E., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202001386r · Cited by 26
Human Deafness Mutation of Myosin VI (C442Y) Accelerates the ADP Dissociation Rate
Satō, O., White, H. D., Inoue, A., Belknap, B., Ikebe, R., & Ikebe, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314332200 · Cited by 26
Bile salt signaling and bile salt-based therapies in cardiometabolic disease
Groenen, C., Nguyen, T.-A., Paulusma, C. C., & van de Graaf, S. F. J. (2024) · Clinical Science · doi:10.1042/cs20230934 · Cited by 26
“Conjugation does not substantially change this order of activation efficacy [22].”
BackgroundBile acid 7α-dehydroxylating bacteria accelerate injury-induced mucosal healing in the colon
Jalil, A., Perino, A., Dong, Y., Imbach, J., Volet, C., Oton, E. V., Demagny, H., Plantade, L., Gallart‐Ayala, H., Ivanišević, J., et al. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00202-w · Cited by 26
“The signaling function of 7 α -dehydroxylated BAs relies on dedicated receptors (Perino and Schoonjans, 2022), such as Takeda-G-protein-receptor-5 (TGR5, GPBAR1) (Kawamata et al, 2003), whose activation drives host processes, including gut hormone secretion (Thomas et al, 2009; Kuhre et al, 2018; 1 Laboratory of Metab…”
Research Progress on the Mechanism of Bile Acids and Their Receptors in Depression
Zhao, X., Zheng, I., Huang, W., Tang, D., Zhao, M., Hou, R., Huang, Y., Shi, Y., Zhu, W., & Wang, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094023 · Cited by 30
“LCA has the highest affinity for TGR5, followed by DCA, CDCA, and CA. TGR5 is predominantly expressed in the liver, spleen, intestine, brain, and fat tissues, with high expression levels in macrophages [16,17].”
Ni, C., Wang, L., Bai, Y., Huang, F., Shi, H., Wu, H., Wu, X., & Huang, J. L. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.04.053 · Cited by 26
Secondary bile acids as immune and metabolic mediators
Fiorucci, S., Biagioli, M., Marchianò, S., Zampella, A., & Distrutti, E. (2026) · Trends in Immunology · doi:10.1016/j.it.2025.12.008 · Cited by 28
Progress in research on the roles of TGR5 receptor in liver diseases
Ma, K., Tang, D., Yu, C. J., & Zhao, L. (2021) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2021.1903547 · Cited by 25
“It is most highly expressed in the gallbladder and adipose tissue, followed by the placenta and spleen [4].”
BackgroundRoles of bile acids in enteric virus replication
Kong, F., Saif, L. J., & Wang, Q. (2021) · Animal Diseases · doi:10.1186/s44149-021-00003-x · Cited by 27
Aberrant Gut-To-Brain Signaling in Irritable Bowel Syndrome - The Role of Bile Acids
Dhonnabháín, R. N., Xiao, Q., & O’Malley, D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.745190 · Cited by 28
“LCA is the most potent natural agonist of TGR5, which is expressed at high levels in the liver and intestinal tissue (40), but is also found in many other tissue types.”
BackgroundInfluentialMu, R.-H., Wu, X. G., Yuan, D., Zhao, J., Tang, S., Hong, H., & Long, Y. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3716609 · Cited by 28
“acid membrane receptor TGR5 can regulate energy homeostasis and glucose metabolism in cells in vitro [64].”
BackgroundDietary resistant starch supplementation increases gut luminal deoxycholic acid abundance in mice
Reuter, M. A., Tucker, M., Marfori, Z., Shishani, R., Bustamante, J. M., Moreno, R., Goodson, M. L., Ehrlich, A. K., Taha, A. Y., Lein, P. J., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2315632 · Cited by 25
Spomer, L., Gertzen, C. G. W., Schmitz, B., Häussinger, D., Gohlke, H., & Keitel, V. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.502344 · Cited by 25
“Luciferase activity served as a measure for the rise in intracellular cAMP after TGR5 activation by TLC, which is the most potent endogenous agonist for this receptor (1, 2, 6).”
Bile Acids Repress Hypoxia-Inducible Factor 1 Signaling and Modulate the Airway Immune Response
Legendre, C., Reen, F. J., Woods, D. F., Mooij, M. J., Adams, C., & O’Gara, F. (2014) · Infection and Immunity · doi:10.1128/iai.00674-13 · Cited by 27
“This was in contrast to the results for serotype 10 LPS (Sigma-Aldrich) used at 0.1 or 10 g/ml for 4 h or 16 h, which did not impact cytokine levels (Fig.”
BackgroundInfluentialShan, J., Oshima, T., Fukui, H., Watari, J., & Miwa, H. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12139 · Cited by 28
Duodenal Luminal Chemosensing; Acid, ATP, and Nutrients
Akiba, Y., & Kaunitz, J. D. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990565 · Cited by 25
Fiorucci, S., & Distrutti, E. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.07.040 · Cited by 25
A Narrative Review of Potential Future Antidiabetic Drugs: Should We Expect More?
Chikara, G., Sharma, P. K., Dwivedi, P., Charan, J., Ambwani, S. R., & Singh, S. (2017) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-017-0668-z · Cited by 29
“Bile salts have been found to act as signals on the intracellular nuclear farnesoid X receptor (FXR) [68] and the cell surface Tgr5 G protein-coupled receptor [69].”
BackgroundSerum Bile Acids Profiling in Inflammatory Bowel Disease Patients Treated with Anti-TNFs
Roda, G., Porru, E., Katsanos, K. H., Skamnelos, A., Kyriakidi, K., Fiorino, G., Christodoulou, D. K., Danese, S., & Roda, A. (2019) · Cells · doi:10.3390/cells8080817 · Cited by 25
“BAs are known for their role in lipid transport through enterohepatic circulation, but recently the understanding of their function as agonists of Farnesoid X receptor (FXR) [7] and TGR5 [8] has unlighted other physiological functions, in which they act as enteric hormones.”
BackgroundGlucagon‐Like Peptide 2 Improves Cholestasis in Parenteral Nutrition–Associated Liver Disease
Lim, D. W., Wales, P. W., Josephson, J. K., Nation, P. N., Wizzard, P. R., Sergi, C. M., Field, C. J., Sigalet, D. L., & Turner, J. M. (2014) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607114551968 · Cited by 25
Sasaki, T., Mita, M., Ikari, N., Kuboyama, A., Hashimoto, S., Kaneko, T., Ishiguro, M., Shimizu, M., Inoue, J., & Sato, R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179226 · Cited by 27
Zhao, S., Lin, H., Li, W., Xu, X., Wu, Q., Wang, Z., Shi, J., Chen, Y., Ye, L., Xi, L., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2462261 · Cited by 26
Activation of TGR5 restores AQP2 expression via the HIF pathway in renal ischemia-reperfusion injury
Han, M., Li, S., Xie, H., Liu, Q., Wang, A., Hu, S., Zhao, X., Kong, Y., Wang, W., & Li, C. (2021) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00577.2020 · Cited by 26
Role of gut microbe-derived metabolites in cardiometabolic diseases: Systems based approach
Cao, Y., Aquino-Martínez, R., Hutchison, E. R., Allayee, H., Lusis, A. J., & Rey, F. E. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101557 · Cited by 29
The degradation of TGR5 mediated by Smurf1 contributes to diabetic nephropathy
Lin, Z., Li, S., Xiao, H., Xu, Z., Li, C., Zeng, J., Wang, S., Liu, Z., & Huang, H. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112851 · Cited by 26
Wu, W., Liu, X., Peng, X., Xue, R., Ji, L., Shen, X., Chen, S., Gu, J., & Zhang, S. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.04.048 · Cited by 24
Yoon, J. (2011) · Oncology Reports · doi:10.3892/or.2011.1239 · Cited by 25
“Bile acids, which are natural agonists for tgr5, increase the intracellular cAMp levels in a dose-dependent manner (22). to determine whether UDcA-induced tgr5 activation is an initiating signal leading to UDcA-induced growth suppression, we measured cellular proliferation in Hcc cells either…”
Rafferty, E. P., Wylie, A. R., Hand, K. H., Elliott, C. E., Grieve, D. J., & Green, B. D. (2011) · Biological Chemistry · doi:10.1515/bc.2011.050 · Cited by 22
“Given that TGR5 is more sensitive to lithocholic and deoxycholic acids than chenodeoxycholic acid it is surprising that taurocholic and glycocholic acids were more potent GLP-1 secretagogues than lithocholic acid; however, the affinity and activity of these bile acids for the TGR5 receptor has not yet been investigate…”
BackgroundInfluentialMa, S.-Y., Ning, M., Zou, Q., Feng, Y., Ye, Y., Shen, J., & Leng, Y. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.27 · Cited by 24
Xiong, F., Li, X., Yang, Z., Wang, Y., Gong, W., Huang, J., Chen, C., Liu, P., & Huang, H. (2016) · Endocrine · doi:10.1007/s12020-016-1032-4 · Cited by 26
Kirchweger, B., Kratz, J. M., Ladurner, A., Grienke, U., Langer, T., Dirsch, V. M., & Rollinger, J. M. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00242 · Cited by 25
“Next to the transcription factor farnesoid X receptor (FXR), GPBAR1 was the second receptor discovered to be responsive to bile acids (Maruyama et al., 2002; Kawamata et al., 2003; Keitel et al., 2010; Gertzen et al., 2015).”
BackgroundBile acid composition regulates the manganese transporter Slc30a10 in intestine
Ahmad, T. R., Higuchi, S., Bertaggia, E., Hung, A., Shanmugarajah, N., Guilz, N. C., Gamarra, J. R., & Haeusler, R. A. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.012792 · Cited by 26
Amelioration of Endothelial Dysfunction in Diabetes: Role of Takeda G Protein–Coupled Receptor 5
Cai, Z., Yuan, S., Zhong, Y., Deng, L., Li, J., Tan, X., & Feng, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.637051 · Cited by 23
Microbially conjugated bile salts found in human bile activate the bile salt receptors TGR5 and FXR
Ay, Ü., Leníček, M., Haider, R. S., Claßen, A., van Eijk, H. M. H., Koelfat, K. V. K., van der Kroft, G., Neumann, U. P., Hoffmann, C., Bolm, C., et al. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000383 · Cited by 29
“[26] To test whether MBSCs act as ligands of TGR5, we first assessed receptor activation via the recruitment of a mini-G s protein, using a proximity-based bioluminescence resonance energy transfer assay.”
MethodDarmanto, A. G., Yen, T., Jan, J., Linh, T. T. D., Taliyan, R., Yang, C. H., & Sheu, J. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107564 · Cited by 25
Schlicht, K., Pape, L., Rohmann, N., Knappe, C., Epe, J., Geisler, C., Pohlschneider, D., Brodesser, S., Kruse, L., Rohlfing, M.-E., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2474143 · Cited by 27
Shen, J., Han, X., Zheng, L., Liu, S., Jin, C., Liu, T., Cao, Y., Lei, X., & Yao, J. (2020) · Journal of Nutrition · doi:10.1093/jn/nxaa238 · Cited by 24
1-deoxysphingolipids bind to COUP-TF to modulate lymphatic and cardiac cell development
Wang, T., Wang, Z., de Fabritus, L., Tao, J., Saied, E. M., Lee, H., Ramazanov, B. R., Jackson, B., Burkhardt, D. B., Parker, M., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.10.018 · Cited by 24
Islam, J., Cho, J., Kim, J.-Y., Park, K., Koh, Y.-J., Chung, C. Y., Lee, E., Nam, S. J., Lee, K., Kim, S.-H., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.766919 · Cited by 28
“In this study, we used taurodeoxycholic acid (TDCA), a GPCR19 agonist, because taurine-conjugated BAs activate GPCR19 (46) with less cytotoxicity than unconjugated BAs and glycine-conjugated BAs (47).”
MethodJamuna, N. A., Kamalakshan, A., Dandekar, B. R., Devassy, A. M. C., Mondal, J., & Mandal, S. (2023) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.3c00274 · Cited by 24
Fiorucci, S., Sepe, V., Biagioli, M., Fiorillo, B., Rapacciuolo, P., Distrutti, E., & Zampella, A. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115776 · Cited by 23
Novel therapeutic targets for nonalcoholic fatty liver disease
Eguchi, A., Povero, D., Alkhouri, N., & Feldstein, A. E. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.789502 · Cited by 23
“Beyond their role as ligands for NRs, BAs can also stimulate the G-protein coupled receptor TGR5 which regulates energy expenditure in brown adipose tissue and muscle [40,41] and has been shown to play a role in controlling intestinal GLP-1 release and maintaining glucose homeostasis [42].”
BackgroundNolan, J., Johnston, I. M., & Walters, J. R. F. (2012) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.12.66 · Cited by 25
Gray, D. W., Welsh, M. D., Doherty, S., Mansoor, F., Chevallier, O. P., Elliott, C. T., & Mooney, M. H. (2015) · Veterinary Research · doi:10.1186/s13567-014-0138-z · Cited by 27
“Plasma peak intensities of a number of conjugated Bile Acids (BAs) were found to differ significantly between vaccinated and non-vaccinated calves, with increased TDCA (4.87 FC) after primary vaccine dosage (day 7, prior to observable differences in IgG titre) and increased GCA (1.63 and 2.12 FC) and NDGCA (1.80 and 3…”
BackgroundInfluentialDuboc, H., Tolstanova, G. M., Yuan, P. Q., Wu, V., Kaji, I., Biraud, M., Akiba, Y., Kaunitz, J. D., Million, M., Taché, Y., et al. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12866 · Cited by 24
Bile acid signaling and bariatric surgery
Tian, J., Huang, S., Sun, S., Ding, L., Zhang, E., Liu, Y., & Huang, W. (2017) · Liver Research · doi:10.1016/j.livres.2017.12.007 · Cited by 23
Jia, W. P., & Rajani, C. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-8684-7_8 · Cited by 29
Compound 18 Improves Glucose Tolerance in a Hepatocyte TGR5-dependent Manner in Mice
Holter, M. M., Chirikjian, M. K., Briere, D. A., Maida, A., Sloop, K. W., Schoonjans, K., & Cummings, B. P. (2020) · Nutrients · doi:10.3390/nu12072124 · Cited by 24
“Finally, TGR5 signaling in immune cells decreases inflammatory cytokine secretion [11,21,22], which likely decreases systemic inflammation to improve insulin sensitivity [23].”
BackgroundWei, W., Wang, H., Zhang, Y., Zhang, Y., Niu, B.-Y., Chen, S., Zhang, W., & Yao, S. (2021) · Digestive and Liver Disease · doi:10.1016/j.dld.2021.04.022 · Cited by 25
Oleanolic Acid Improves Gut Atrophy Induced by Parenteral Nutrition
Jain, A. K., Wen, J. X., Blomenkamp, K., Arora, S., Blaufuss, T. A., Rodrigues, J., Long, J. P., Neuschwander‐Tetri, B. A., & Teckman, J. H. (2015) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607115583536 · Cited by 25
“neonates; pediatrics; parenteral nutrition; gut atrophy; gastroenterology; oleanolic acid at NORTHERN ARIZONA UNIVERSITY on June 12, 2015pen.sagepub.comDownloaded from body, regulating homeostatic equilibrium.15–17 For example, animal studies have shown that feeding bile acids induces gut mucosal proliferation,18,19 a…”
BackgroundInfluentialTargeting the TGR5-GLP-1 pathway to combat type 2 diabetes and non-alcoholic fatty liver disease
Pols, T. W. H., Auwerx, J. H., & Schoonjans, K. (2010) · Gastroentérologie Clinique et Biologique · doi:10.1016/j.gcb.2010.03.009 · Cited by 23
Baxter, J. D., & Webb, P. (2006) · Nature · doi:10.1038/439402a · Cited by 23
Fiorucci, S., Urbani, G., Giorgio, C. D., Biagioli, M., & Distrutti, E. (2024) · Cells · doi:10.3390/cells13191650 · Cited by 26
“It is primarily expressed in the ileum, colon, spleen, adipose tissue, and lymphoid tissues [69].”
BackgroundExploring effects of gut microbiota on tertiary lymphoid structure formation for tumor immunotherapy
Liu, Y., Li, F., Wang, J., & Yang, R. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1518779 · Cited by 24
Glycolate is a Novel Marker of Vitamin B2 Deficiency Involved in Gut Microbe Metabolism in Mice
Uebanso, T., Yoshimoto, A., Aizawa, S., Nakamura, M., Masuda, R., Shimohata, T., Mawatari, K., & Takahashi, A. (2020) · Nutrients · doi:10.3390/nu12030736 · Cited by 22
Implications of gut microbiome on coronary artery disease
Xu, J., & Yang, Y. (2020) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-20-428 · Cited by 24
Biagioli, M., Marchianò, S., Roselli, R., Giorgio, C. D., Bellini, R., Bordoni, M., Distrutti, E., Catalanotti, B., Zampella, A., Graziosi, L., et al. (2022) · Cells · doi:10.3390/cells11071187 · Cited by 22
“Secondary bile acids have been identified as the physiological ligands to the cell membrane receptor known as the G protein bile acid receptor (GPBAR)1, also known as TGR5 [19,20].”
BackgroundBile Acids—A Peek Into Their History and Signaling
Nguyen, J. T., Shaw, R. P. H., & Anakk, S. (2022) · Endocrinology · doi:10.1210/endocr/bqac155 · Cited by 24
Deciphering the role of gut metabolites in non-alcoholic fatty liver disease
Ralli, T., Saifi, Z., Tyagi, N., Vidyadhari, A., Aeri, V., & Kohli, K. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2142091 · Cited by 23
“…stimulates cAMP which have two effects a) stimulate thyroid activating enzyme (D2) which in turn causes thermo-genesis and b) stimulate PGC-1alpha which stimulates beta-oxidation and increases metabolic activity and decreased adipocity (Maruyama et al. 2002; Kawamata et al. 2003) (Figure 5).”
Background
Metadata
- Authors
- Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., Hinuma, S., Fujisawa, Y., & Fujino, M.
- Affiliations
- Takeda (Japan) (JP)
- Corresponding author
- Hinuma, Shuji
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 278
- Issue
- 11
- Pages
- 9435-9440
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2096418655
- Cited by
- 1,628
- References
- 27
- Citations by year
- 2026: 96 · 2025: 90 · 2024: 114 · 2023: 122 · 2022: 101 · 2021: 114 · 2020: 100 · 2019: 99 · 2018: 108 · 2017: 99 · 2016: 77 · 2015: 76 · 2014: 71 · 2013: 75 · 2012: 50
- FWCI
- 6.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6433 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- TGR5, G protein-coupled receptors, bile acids, cell surface receptors, receptor internalization, ERK MAP kinase, cAMP production, macrophages, monocytes, phagocytosis, cytokine production, lipopolysaccharide, THP-1 cells, alveolar macrophages
- MeSH terms
- Cyclic AMP, Amino Acid Sequence, Animals, Bile Acids and Salts, Cell Line, Cell Membrane, Dose-Response Relationship, Drug, Genetic Vectors, Cricetinae, Humans, Luminescent Proteins, Macrophages, Molecular Sequence Data, Phagocytosis, Protein Binding, Rabbits, Receptors, Cell Surface, Recombinant Fusion Proteins, RNA, Messenger, Time Factors, Tissue Distribution, Transfection, Cytokines, Guanosine 5'-O-(3-Thiotriphosphate), CHO Cells, GTP-Binding Proteins, Reverse Transcriptase Polymerase Chain Reaction, Mitogen-Activated Protein Kinases, MAP Kinase Signaling System, Receptors, G-Protein-Coupled, Green Fluorescent Proteins, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.